Showing results (251-260 of 555) with videos related to
Sort By:
Pageof 56
Archives of Dermatological Research|November 13, 2021
Associations between onychomycosis and COVID-19 clinical outcomes: a retrospective cohort study from a US metropolitan centerUros Rakita, Trisha Kaundinya, Armaan Guraya, et al.American Journal of Clinical Dermatology|August 30, 2018
A Comprehensive Conceptual Model of the Experience of Chronic Itch in AdultsJonathan I Silverberg, Robert W Kantor, Prarthana Dalal, et al.Dermatology and Therapy|February 4, 2025
Switching from Dupilumab to Abrocitinib in Patients With Moderate-to-Severe Atopic Dermatitis: A Post Hoc Analysis of Efficacy After Treatment With Dupilumab in JADE DAREJonathan I Silverberg, Eric L Simpson, Andrew E Pink, et al.Archives of Dermatological Research|March 12, 2025
Burden of mild and moderate atopic dermatitis in adults: results from a real-world study in the United StatesJonathan I Silverberg, Peter Anderson, Joseph C Cappelleri, et al.Dermatology and Therapy|July 30, 2024
Efficacy of Upadacitinib and Dupilumab on Achieving Stringent and Composite Skin and Itch Outcomes: an Indirect Comparison of Adults with Moderate-to-Severe Atopic DermatitisApril W Armstrong, H Chih-Ho Hong, Brian M Calimlim, et al.Archives of Dermatological Research|March 20, 2024
Validation of the Investigator Global Assessment of Chronic Hand Eczema (IGA-CHE): a new clinician reported outcome measure of CHE severityJonathan I Silverberg, Tove Agner, Keith Baranowski, et al.American Journal of Clinical Dermatology|October 26, 2021
Expert Perspectives on Key Parameters that Impact Interpretation of Randomized Clinical Trials in Moderate-to-Severe Atopic DermatitisJonathan I Silverberg, Eric L Simpson, April W Armstrong, et al.Journal of the American Academy of Dermatology|October 22, 2023
Safety and efficacy of eblasakimab, an interleukin 13 receptor α1 monoclonal antibody, in adults with moderate-to-severe atopic dermatitis: A phase 1b, multiple-ascending dose studyKaren A Veverka, Steven T G Thng, Jonathan I Silverberg, et al.Dermatology and Therapy|April 30, 2021
Risk of Venous Thromboembolism Among Patients with Atopic Dermatitis: A Cohort Study in a US Administrative Claims DatabaseKristin J Meyers, Jonathan I Silverberg, Maria Jose Rueda, et al.Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|July 17, 2022
Patient-oriented measures for phase 3 studies of tralokinumab for the treatment of atopic dermatitis (ECZTRA 1, 2, and 3)Eric L Simpson, Andreas Wollenberg, Weily Soong, et al.Pageof 56